Symbols / ILMN
ILMN Chart
About
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 18.78B |
| Enterprise Value | 19.71B | Income | 850.00M | Sales | 4.34B |
| Book/sh | 17.80 | Cash/sh | 10.68 | Dividend Yield | — |
| Payout | 0.00% | Employees | 8600 | IPO | — |
| P/E | 22.58 | Forward P/E | 21.02 | PEG | — |
| P/S | 4.32 | P/B | 6.90 | P/C | — |
| EV/EBITDA | 17.31 | EV/Sales | 4.54 | Quick Ratio | 1.58 |
| Current Ratio | 2.08 | Debt/Eq | 93.76 | LT Debt/Eq | — |
| EPS (ttm) | 5.44 | EPS next Y | 5.85 | EPS Growth | 86.40% |
| Revenue Growth | 5.00% | Earnings | 2026-05-07 | ROA | 8.39% |
| ROE | 33.36% | ROIC | — | Gross Margin | 68.25% |
| Oper. Margin | 19.67% | Profit Margin | 19.57% | Shs Outstand | 152.90M |
| Shs Float | 148.65M | Short Float | 8.48% | Short Ratio | 4.32 |
| Short Interest | — | 52W High | 155.53 | 52W Low | 68.70 |
| Beta | 1.45 | Avg Volume | 1.96M | Volume | 368.70K |
| Target Price | $136.05 | Recom | Buy | Prev Close | $122.90 |
| Price | $122.84 | Change | -0.04% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$136.05
Mean price target
2. Current target
$122.85
Latest analyst target
3. DCF / Fair value
$92.53
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$122.85
Low
$80.00
High
$170.00
Mean
$136.05
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-09 | main | Piper Sandler | Overweight → Overweight | $170 |
| 2026-02-06 | main | JP Morgan | Neutral → Neutral | $120 |
| 2026-01-26 | main | Guggenheim | Buy → Buy | $170 |
| 2026-01-26 | main | Canaccord Genuity | Hold → Hold | $150 |
| 2026-01-20 | main | Stifel | Buy → Buy | $155 |
| 2026-01-07 | main | TD Cowen | Hold → Hold | $140 |
| 2026-01-05 | main | Guggenheim | Buy → Buy | $144 |
| 2025-12-22 | main | Canaccord Genuity | Hold → Hold | $130 |
| 2025-12-15 | main | Barclays | Underweight → Underweight | $110 |
| 2025-12-15 | main | JP Morgan | Neutral → Neutral | $130 |
| 2025-10-31 | main | Barclays | Underweight → Underweight | $100 |
| 2025-10-31 | main | Canaccord Genuity | Hold → Hold | $112 |
| 2025-10-31 | main | JP Morgan | Neutral → Neutral | $105 |
| 2025-10-31 | main | TD Cowen | Hold → Hold | $115 |
| 2025-10-31 | main | UBS | Neutral → Neutral | $120 |
| 2025-10-31 | main | Baird | Neutral → Neutral | $109 |
| 2025-10-31 | main | Evercore ISI Group | Outperform → Outperform | $142 |
| 2025-10-07 | main | Evercore ISI Group | Outperform → Outperform | $132 |
| 2025-10-02 | main | Barclays | Underweight → Underweight | $95 |
| 2025-08-04 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $105 |
- How Illumina multiomics helps scientists track elusive ovarian cancers - Stock Titan Wed, 25 Feb 2026 14
- Assessing Illumina (ILMN) Valuation After Recent Share Price Rebound And Longer Term Volatility - Yahoo Finance Wed, 25 Feb 2026 04
- Illumina, Inc. (ILMN) Stock Analysis: Exploring a 15.62% Potential Upside in the Genomics Sector - DirectorsTalk Interviews Mon, 23 Feb 2026 19
- Top Illumina Executive Makes Notable Insider Stock Move - TipRanks Wed, 25 Feb 2026 04
- Illumina Beat Q4 Earnings and Closed a $350M Acquisition. Here’s What Investors Need to Know - TIKR.com Sat, 21 Feb 2026 23
- Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 - PR Newswire hu, 05 Feb 2026 08
- The Bull Case For Illumina (ILMN) Could Change Following Buybacks And NovaSeq X Roadmap Reveal – Learn Why - simplywall.st ue, 24 Feb 2026 01
- ILMN Stock Falls -23% With A 10-day Losing Spree On Analyst Price Target Cuts - Trefis ue, 10 Feb 2026 05
- $ILMN stock is down 10% today. Here's what we see in our data. - Quiver Quantitative Fri, 06 Feb 2026 19
- Illumina's TruPath Genome offers rapid whole genome testing for rare disease - Stock Titan ue, 24 Feb 2026 17
- Why Illumina (ILMN) Stock Is Up Today - Yahoo Finance Fri, 31 Oct 2025 07
- ILMN Stock Falls -22% With A 9-day Losing Spree On Weak Revenue Guidance - Trefis Sat, 07 Feb 2026 08
- Illumina Stock is Down 80% From Its All-Time Highs: Can It Recover in 2026? - TIKR.com Wed, 18 Feb 2026 19
- Faster DNA decoding: Illumina’s NovaSeq X gets 40% more data, higher accuracy - Stock Titan Mon, 23 Feb 2026 14
- Is It Time To Reassess Illumina (ILMN) After Recent Share Price Volatility - Yahoo Finance hu, 19 Feb 2026 13
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1336 | 155216.0 | — | Sale at price 116.18 per share. | DAVIES SCOTT M | Officer | — | 2026-02-20 00:00:00 | D |
| 1 | 2370 | 275347.0 | — | Sale at price 116.18 per share. | LECKMAN PATRICIA | Officer | — | 2026-02-18 00:00:00 | D |
| 2 | 2283 | nan | — | — | PEGELS KEVIN CARL | Officer | — | 2026-02-12 00:00:00 | D |
| 3 | 743 | nan | — | — | ERICKSEN SCOTT D | Officer | — | 2026-02-12 00:00:00 | D |
| 4 | 2677 | nan | — | — | BARNARD STEVEN | Chief Technology Officer | — | 2026-02-12 00:00:00 | D |
| 5 | 1028 | nan | — | — | LECKMAN PATRICIA | Officer | — | 2026-02-12 00:00:00 | D |
| 6 | 1370 | nan | — | — | DAVIES SCOTT M | Officer | — | 2026-02-12 00:00:00 | D |
| 7 | 13264 | nan | — | — | THAYSEN JACOB | Chief Executive Officer | — | 2026-02-12 00:00:00 | D |
| 8 | 200 | 23562.0 | — | Purchase at price 117.81 per share. | GOTTLIEB SCOTT | Director | — | 2026-02-09 00:00:00 | D |
| 9 | 212 | 24938.0 | — | Stock Award(Grant) at price 117.63 per share. | ULLEM SCOTT B | Director | — | 2025-12-31 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -2.17M | -300.93M | -177.87M | -951.93M |
| TaxRateForCalcs | 0.22 | 0.21 | 0.21 | 0.21 |
| NormalizedEBITDA | 1.47B | 708.00M | 239.00M | 617.00M |
| TotalUnusualItems | -10.00M | -1.43B | -847.00M | -4.53B |
| TotalUnusualItemsExcludingGoodwill | -10.00M | -1.43B | -847.00M | -4.53B |
| NetIncomeFromContinuingOperationNetMinorityInterest | 850.00M | -1.22B | -1.16B | -4.40B |
| ReconciledDepreciation | 270.00M | 354.00M | 432.00M | 394.00M |
| ReconciledCostOfRevenue | 1.47B | 1.51B | 1.76B | 1.61B |
| EBITDA | 1.46B | -725.00M | -608.00M | -3.92B |
| EBIT | 1.19B | -1.08B | -1.04B | -4.31B |
| NetInterestIncome | -61.00M | -54.00M | -19.00M | -15.00M |
| InterestExpense | 101.00M | 100.00M | 77.00M | 26.00M |
| InterestIncome | 40.00M | 46.00M | 58.00M | 11.00M |
| NormalizedIncome | 857.83M | -90.93M | -491.87M | -822.93M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 850.00M | -1.22B | -1.16B | -4.40B |
| TotalExpenses | 3.53B | 3.77B | 4.73B | 4.23B |
| TotalOperatingIncomeAsReported | 807.00M | -833.00M | -1.07B | -4.18B |
| DilutedAverageShares | 159.00M | 158.00M | 157.00M | 151.00M |
| BasicAverageShares | 159.00M | 158.00M | 157.00M | 150.00M |
| DilutedEPS | -7.69 | -7.34 | -28.00 | 5.04 |
| BasicEPS | -7.69 | -7.34 | -28.00 | 5.07 |
| DilutedNIAvailtoComStockholders | 850.00M | -1.22B | -1.16B | -4.40B |
| NetIncomeCommonStockholders | 850.00M | -1.22B | -1.16B | -4.40B |
| NetIncome | 850.00M | -1.22B | -1.16B | -4.40B |
| MinorityInterests | 0.00 | |||
| NetIncomeIncludingNoncontrollingInterests | 850.00M | -1.22B | -1.16B | -4.40B |
| NetIncomeContinuousOperations | 850.00M | -1.22B | -1.16B | -4.40B |
| TaxProvision | 236.00M | 44.00M | 44.00M | 68.00M |
| PretaxIncome | 1.09B | -1.18B | -1.12B | -4.34B |
| OtherIncomeExpense | 330.00M | -1.73B | -876.00M | -4.67B |
| OtherNonOperatingIncomeExpenses | 340.00M | -292.00M | -29.00M | -142.00M |
| SpecialIncomeCharges | -10.00M | -1.43B | -847.00M | -4.53B |
| GainOnSaleOfBusiness | 0.00 | |||
| OtherSpecialCharges | 10.00M | -456.00M | 20.00M | 619.00M |
| ImpairmentOfCapitalAssets | 0.00 | 1.89B | 827.00M | 3.91B |
| RestructuringAndMergernAcquisition | 0.00 | 0.00 | -86.00M | |
| GainOnSaleOfSecurity | -30.00M | -129.00M | 973.00M | |
| NetNonOperatingInterestIncomeExpense | -61.00M | -54.00M | -19.00M | -15.00M |
| InterestExpenseNonOperating | 101.00M | 100.00M | 77.00M | 26.00M |
| InterestIncomeNonOperating | 40.00M | 46.00M | 58.00M | 11.00M |
| OperatingIncome | 817.00M | 600.00M | -222.00M | 354.00M |
| OperatingExpense | 2.05B | 2.26B | 2.97B | 2.62B |
| ResearchAndDevelopment | 967.00M | 1.17B | 1.35B | 1.32B |
| SellingGeneralAndAdministration | 1.09B | 1.09B | 1.61B | 1.30B |
| GrossProfit | 2.87B | 2.86B | 2.74B | 2.97B |
| CostOfRevenue | 1.47B | 1.51B | 1.76B | 1.61B |
| TotalRevenue | 4.34B | 4.37B | 4.50B | 4.58B |
| OperatingRevenue | 4.34B | 4.37B | 4.50B | 4.58B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 48.00M | 41.00M | 40.00M | 40.00M |
| OrdinarySharesNumber | 153.00M | 159.00M | 159.00M | 158.00M |
| ShareIssued | 201.00M | 200.00M | 199.00M | 198.00M |
| NetDebt | 571.00M | 862.00M | 441.00M | 724.00M |
| TotalDebt | 2.55B | 2.62B | 2.26B | 3.56B |
| TangibleBookValue | 1.40B | 965.00M | 207.00M | 75.00M |
| InvestedCapital | 4.71B | 4.36B | 7.23B | 9.33B |
| WorkingCapital | 1.70B | 1.20B | 1.04B | 788.00M |
| NetTangibleAssets | 1.40B | 965.00M | 207.00M | 75.00M |
| CapitalLeaseObligations | 564.00M | 633.00M | 773.00M | 820.00M |
| CommonStockEquity | 2.72B | 2.37B | 5.75B | 6.60B |
| TotalCapitalization | 4.21B | 3.86B | 7.23B | 8.09B |
| TotalEquityGrossMinorityInterest | 2.72B | 2.37B | 5.75B | 6.60B |
| StockholdersEquity | 2.72B | 2.37B | 5.75B | 6.60B |
| GainsLossesNotAffectingRetainedEarnings | -10.00M | 22.00M | -1.00M | 3.00M |
| OtherEquityAdjustments | -10.00M | 22.00M | -1.00M | 3.00M |
| TreasuryStock | 4.70B | 3.93B | 3.79B | 3.75B |
| RetainedEarnings | -392.00M | -1.24B | -19.00M | 1.14B |
| AdditionalPaidInCapital | 7.82B | 7.53B | 9.55B | 9.21B |
| CapitalStock | 2.00M | 2.00M | 2.00M | 2.00M |
| CommonStock | 2.00M | 2.00M | 2.00M | 2.00M |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 3.92B | 3.93B | 4.37B | 5.65B |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 2.34B | 2.38B | 2.80B | 2.88B |
| OtherNonCurrentLiabilities | 360.00M | 339.00M | 620.00M | 649.00M |
| LongTermDebtAndCapitalLeaseObligation | 1.98B | 2.04B | 2.18B | 2.23B |
| LongTermCapitalLeaseObligation | 486.00M | 554.00M | 687.00M | 744.00M |
| LongTermDebt | 1.49B | 1.49B | 1.49B | 1.49B |
| CurrentLiabilities | 1.58B | 1.55B | 1.57B | 2.77B |
| CurrentDeferredLiabilities | 270.00M | 260.00M | 252.00M | 245.00M |
| CurrentDeferredRevenue | 270.00M | 260.00M | 252.00M | 245.00M |
| CurrentDebtAndCapitalLeaseObligation | 577.00M | 578.00M | 86.00M | 1.32B |
| CurrentCapitalLeaseObligation | 78.00M | 79.00M | 86.00M | 76.00M |
| CurrentDebt | 499.00M | 499.00M | 1.25B | |
| OtherCurrentBorrowings | 499.00M | 499.00M | 1.25B | |
| CurrentNotesPayable | 500.00M | 0.00 | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 249.00M | 252.00M | 223.00M | 188.00M |
| PayablesAndAccruedExpenses | 489.00M | 457.00M | 1.01B | 1.02B |
| CurrentAccruedExpenses | 142.00M | 135.00M | 685.00M | 626.00M |
| Payables | 347.00M | 322.00M | 324.00M | 390.00M |
| TotalTaxPayable | 107.00M | 101.00M | 79.00M | 97.00M |
| AccountsPayable | 240.00M | 221.00M | 245.00M | 293.00M |
| TotalAssets | 6.64B | 6.30B | 10.11B | 12.25B |
| TotalNonCurrentAssets | 3.35B | 3.56B | 7.50B | 8.69B |
| OtherNonCurrentAssets | 449.00M | 348.00M | 357.00M | 423.00M |
| NonCurrentDeferredAssets | 454.00M | 567.00M | 56.00M | |
| NonCurrentDeferredTaxesAssets | 454.00M | 567.00M | 56.00M | |
| GoodwillAndOtherIntangibleAssets | 1.32B | 1.41B | 5.54B | 6.52B |
| OtherIntangibleAssets | 210.00M | 295.00M | 2.99B | 3.29B |
| Goodwill | 1.11B | 1.11B | 2.54B | 3.24B |
| NetPPE | 1.13B | 1.23B | 1.55B | 1.74B |
| AccumulatedDepreciation | -1.36B | -1.25B | -1.14B | -962.00M |
| GrossPPE | 2.49B | 2.49B | 2.69B | 2.71B |
| Leases | 755.00M | 772.00M | 803.00M | 759.00M |
| ConstructionInProgress | 82.00M | 39.00M | 96.00M | 132.00M |
| OtherProperties | 370.00M | 419.00M | 544.00M | 653.00M |
| MachineryFurnitureEquipment | 1.24B | 1.21B | 1.20B | 1.12B |
| BuildingsAndImprovements | 44.00M | 44.00M | 44.00M | 44.00M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 3.29B | 2.75B | 2.61B | 3.56B |
| OtherCurrentAssets | 238.00M | 244.00M | 234.00M | 285.00M |
| PrepaidAssets | 295.00M | |||
| Inventory | 564.00M | 547.00M | 587.00M | 568.00M |
| InventoriesAdjustmentsAllowances | -133.00M | -113.00M | -121.00M | -93.00M |
| FinishedGoods | 45.00M | 31.00M | 30.00M | 28.00M |
| WorkInProcess | 398.00M | 404.00M | 402.00M | 386.00M |
| RawMaterials | 254.00M | 225.00M | 276.00M | 247.00M |
| Receivables | 854.00M | 735.00M | 734.00M | 671.00M |
| AccountsReceivable | 854.00M | 735.00M | 734.00M | 671.00M |
| AllowanceForDoubtfulAccountsReceivable | -7.00M | -9.00M | -7.00M | -4.00M |
| GrossAccountsReceivable | 861.00M | 744.00M | 741.00M | 675.00M |
| CashCashEquivalentsAndShortTermInvestments | 1.63B | 1.22B | 1.05B | 2.04B |
| OtherShortTermInvestments | 215.00M | 93.00M | 6.00M | 26.00M |
| CashAndCashEquivalents | 1.42B | 1.13B | 1.05B | 2.01B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 931.00M | 709.00M | 283.00M | 106.00M |
| RepurchaseOfCapitalStock | -742.00M | -116.00M | 0.00 | 0.00 |
| RepaymentOfDebt | -500.00M | -750.00M | -1.24B | 0.00 |
| IssuanceOfDebt | 495.00M | 1.24B | 0.00 | 991.00M |
| IssuanceOfCapitalStock | 44.00M | 56.00M | 67.00M | 63.00M |
| CapitalExpenditure | -148.00M | -128.00M | -195.00M | -286.00M |
| InterestPaidSupplementalData | 95.00M | 83.00M | 73.00M | 17.00M |
| IncomeTaxPaidSupplementalData | 73.00M | 105.00M | 65.00M | 122.00M |
| EndCashPosition | 1.42B | 1.13B | 1.05B | 2.01B |
| BeginningCashPosition | 1.13B | 1.05B | 2.01B | 1.23B |
| EffectOfExchangeRateChanges | 11.00M | -10.00M | 0.00 | -22.00M |
| ChangesInCash | 280.00M | 89.00M | -963.00M | 801.00M |
| FinancingCashFlow | -744.00M | -570.00M | -1.21B | 1.00B |
| CashFlowFromContinuingFinancingActivities | -744.00M | -570.00M | -1.21B | 1.00B |
| NetOtherFinancingCharges | -41.00M | -1.00B | -41.00M | -54.00M |
| NetCommonStockIssuance | -698.00M | -60.00M | 67.00M | 63.00M |
| CommonStockPayments | -742.00M | -116.00M | 0.00 | 0.00 |
| CommonStockIssuance | 44.00M | 56.00M | 67.00M | 63.00M |
| NetIssuancePaymentsOfDebt | -5.00M | 491.00M | -1.24B | 991.00M |
| NetLongTermDebtIssuance | -5.00M | 491.00M | -1.24B | 991.00M |
| LongTermDebtPayments | -500.00M | -750.00M | -1.24B | 0.00 |
| LongTermDebtIssuance | 495.00M | 1.24B | 0.00 | 991.00M |
| InvestingCashFlow | -55.00M | -178.00M | -231.00M | -591.00M |
| CashFlowFromContinuingInvestingActivities | -55.00M | -178.00M | -231.00M | -591.00M |
| NetInvestmentPurchaseAndSale | 103.00M | -52.00M | -6.00M | -40.00M |
| SaleOfInvestment | 0.00 | 0.00 | 1.66B | |
| PurchaseOfInvestment | -52.00M | -6.00M | -40.00M | -77.00M |
| NetBusinessPurchaseAndSale | -10.00M | 2.00M | -30.00M | -265.00M |
| SaleOfBusiness | 0.00 | 83.00M | 0.00 | 0.00 |
| PurchaseOfBusiness | -10.00M | -81.00M | -30.00M | -265.00M |
| NetIntangiblesPurchaseAndSale | -1.00M | -180.00M | 0.00 | |
| PurchaseOfIntangibles | -1.00M | -180.00M | 0.00 | |
| NetPPEPurchaseAndSale | -148.00M | -128.00M | -195.00M | -286.00M |
| PurchaseOfPPE | -148.00M | -128.00M | -195.00M | -286.00M |
| OperatingCashFlow | 1.08B | 837.00M | 478.00M | 392.00M |
| CashFlowFromContinuingOperatingActivities | 1.08B | 837.00M | 478.00M | 392.00M |
| ChangeInWorkingCapital | -153.00M | -483.00M | -90.00M | 204.00M |
| ChangeInOtherWorkingCapital | -34.00M | -32.00M | -16.00M | -8.00M |
| ChangeInOtherCurrentLiabilities | 33.00M | 28.00M | -1.00M | -19.00M |
| ChangeInOtherCurrentAssets | -21.00M | -15.00M | 5.00M | 19.00M |
| ChangeInPayablesAndAccruedExpense | 2.00M | -444.00M | -29.00M | 343.00M |
| ChangeInAccruedExpense | 0.00 | -440.00M | 15.00M | 381.00M |
| ChangeInPayable | 2.00M | -4.00M | -44.00M | -38.00M |
| ChangeInAccountPayable | 2.00M | -4.00M | -44.00M | -38.00M |
| ChangeInPrepaidAssets | -8.00M | -14.00M | 11.00M | 16.00M |
| ChangeInInventory | -17.00M | 19.00M | -20.00M | -135.00M |
| ChangeInReceivables | -108.00M | -25.00M | -40.00M | -12.00M |
| ChangesInAccountReceivables | -108.00M | -25.00M | -40.00M | -12.00M |
| OtherNonCashItems | 19.00M | -316.00M | -17.00M | -190.00M |
| StockBasedCompensation | 275.00M | 370.00M | 380.00M | 366.00M |
| UnrealizedGainLossOnInvestmentSecurities | 22.00M | 1.00M | 0.00 | |
| AssetImpairmentCharge | 27.00M | 1.94B | 927.00M | 3.92B |
| DeferredTax | 119.00M | -112.00M | -33.00M | -23.00M |
| DeferredIncomeTax | 119.00M | -112.00M | -33.00M | -23.00M |
| DepreciationAmortizationDepletion | 270.00M | 354.00M | 432.00M | 394.00M |
| DepreciationAndAmortization | 270.00M | 354.00M | 432.00M | 394.00M |
| AmortizationCashFlow | 67.00M | 130.00M | 197.00M | 179.00M |
| AmortizationOfIntangibles | 67.00M | 130.00M | 197.00M | 179.00M |
| Depreciation | 203.00M | 224.00M | 235.00M | 215.00M |
| OperatingGainsLosses | -328.00M | 312.00M | 40.00M | 122.00M |
| EarningsLossesFromEquityInvestments | 0.00 | 0.00 | -899.00M | |
| GainLossOnInvestmentSecurities | -328.00M | 312.00M | 40.00M | 122.00M |
| GainLossOnSaleOfBusiness | 0.00 | |||
| NetIncomeFromContinuingOperations | 850.00M | -1.22B | -1.16B | -4.40B |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ILMN
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|